1/78
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
which drugs act on the proximal tubule
carbonic anhydrase inhibitors
SGLT2 inhibitors
which drugs act on the descending loop
osmotic agents
which drugs act on the ascending loop
loop diuretics
which drugs act on the collecting duct
potassium sparing diuretics
aldosterone antagonists
ADH agonists and antagonists
which drugs act on the distal tubule
thiazide diuretics
describe the mechanism of action of carbonic anhydrase inhibitors
inhibits reabsorption of bicarbonate in the proximal tubule
alkalises the urine
blood becomes more acidic
main use of carbonic anhydrase inhibitors
glaucoma
name the 3 carbonic anhydrase inhibitors
acetazolamide
brinzolamide
dorzolamide
acetazolamide
- formulation
- indication
- oral
- glaucoma, altitude sickness
brinzolamide and dorzolamide
- formulation
- indication
- eye drops
- open angle glaucoma/ ocular hypotension
SGLT2 meaning
sodium glucose co transporter 2
what is another name for SGLT2 inhibitors
gliflozins
name 5 SGLT2 inhibitors
Dapagliflozin, Canagliflozin, Empagliflozin, Ertugliflozin
what do the SGLT2 inhibitors do
selectively and reversible inhibit SGLT2
what does the inhibition of SGLT2 lead to
reduces reabsorption of glucose
reduces sodium reabsorbtion
what does the reduction of glucose and sodium reabsorption result in
urinary excretion of glucose and osmotic diuresis
what does an increase of sodium in the distal tubule lead to
a decrease in intraglomerular pressure
-> leads to reduction of volume overload, reduce BP, lower preload and afterload
all of which are beneficial to the heart
adverse effects of SGLT2 inhibitors
vulvovaginitis
balanitis (inflamed penis)
UTI
constipation, nausea, thirst
fourniers gangrene - pain in genitalia
SGLT2 interactions
thiazide and loop diuretics - dehydration and hypotension
other antihypertensives - hypotension
insulin and insulin secretagogues - hypoglycaemia
osmotic agents (mannitol) - what does it act on
proximal tubule
descending loop of henle
collecting ducts
mannitol MOA
- inhibits passive water reabsorption -> this leads to an increase in tubular fluid volume
- draws water
- secondary decrease in Na+ reabsorption
- Na+ is filtered -> causes osmotic diuresis
How is mannitol administered?
IV
not absorbed orally
clinical uses of mannitol
- decrease intracranial pressure and intraocular pressure
- acute renal failure
osmotic agents adverse effects
transient expansion of extracellular fluid volume
hypotraemia
headache
nausea
vomiting
osmotic agents interactions
- nephrotoxic drugs - kidney damage
- neurotoxic drugs - CNS toxicity
- diuretics - may potentiate effects
name 2 thiazide diuretics
Bendroflumethiazide
Hydrochlorothiazide
name 2 thiazide like diuretics
• Chlortalidone • Indapamide
thiazide (like) diuretics MOA
- block distal renal tubular reabsorption
- bind to the Cl- site on the Na+/Cl- co-transport system
- inhibits action of co-transporter
- causes natriuresis with loss of Na+ and Cl- in the urine
what are the 2 types of potassium sparing diuretics
amiloride
aldosterone antagonists
amiloride site of action
collecting tubules and collecting ducts
amiloride MOA
- block luminal epithelial sodium channels (ENAC)
- decrease Na reabsorption and K excretion
- action is independent of aldosterone
effect of amiloride
limited diuretic efficacy
adds to the natriuretic effect
reduces kaliuretic effect of other diuretics
amiloride use
combined with thiazide/loop diuretics to prevent hypokalaemia
alternative to oral potassium supplements
amiloride adverse effects
hyperkalemia
GI disturbances - nausea, vomiting, diarrhoea
amiloride interactions
ACE
ARB
Potassium salts
NSAID
Digoxin
name 2 aldosterone antagonists
spironolactone
eplerenone
aldosterone antagonists MOA
- compete with aldosterone for intracellular receptor
- decrease Na reabsorbtion and K secretion
- weak diuretic effect
clinical use of potassium sparing diuretics
oedema assoc with HF
severe HF
adjuvant in resistant hypertension
primary/secondary hyperaldosteronism
aldosterone antagonists adverse effects
hyperkalemia
GI upset
gynaecomastia
menstrual disorders
testicular atrophy
aldosterone antagonists interactions
ACE
ARB
other drugs increasing K+
antihypertensives
name an antidiuretic hormone (ADH) agonist
desmopressin
what is desmopressin an analogue of
vasopressin
desmopressin clinical indications
diagnosis and treatment of central diabetes insipidus
symptomatic treatment of nocturia in adults
haemophilia
von Willebrands disease
name an ADH antagonist
tolvaptan
tolvaptan use
vasopressin receptor antagonist
polycyctic kidney disease treatment
hyponatraemia secondary to SIADH
ADH agonist adverse effects
hypotraemia
nausea
ADH antagonist adverse effects
• Dehydration
• Dry mouth
• Gout
• Hyperglycaemia
• Hypernatraemia
• Hyperuricaemia
• Thirst
• Polydipsia
• Acute hepatic failure
ADH agonist - desmopressin interactions
lamotrigine
loperamide
ADH antagonist - tolvaptan interactions
concurrent use of drugs increasing serum sodium and/or potassium conc
name 2 loop diuretics
furosemide
bumetanide
loop diuretics MOA
Inhibit Na⁺/K⁺/2Cl⁻ co-transporter in the thick ascending limb of the Loop of Henle
- this normally absorbs 25% filtered Na
what does the inhibition of the co transporter lead to
• ↑ Na⁺ delivery to distal tubule
• ↓ medullary hypertonicity
• ↓ water reabsorption in collecting duct
physiological effects of loop diuretics
powerful diuresis
natriuresis
increased renal blood flow via prostaglandin sunthesis
loop diuretics adverse effects
hypokalemia
exacerbate diabetes
precipitate gout
dose related hearing loss
why should older adults start with lower dose of loop diuretic
as they are more prone to side effects
loop diuretics interactions
NSAIDS - reduced diuretic effect
antihypertensives
PPIs - hypomagnesaemia
aminoglycosides/vanomycin = hearing loss/ ototoxicity
risperidone
benefits of ACE/ARB to kidneys
protective effects on kidneys
patients with diabetes should use them regardless of their BP
causes vasodilation
reduced sodium retention
decreases vasoconstriction
ACE/ ARB negatives
decrease in angiotensin II means the efferent arteriole doesn't constrict so glomerular pressure drops and GFR falls
what is acute kidney injury
abrupt reduction in kidney function
what does acute kidney injury result in
accumulation of nitrogenous waste products and other toxic substances
why are most cases of acute kidney injury hospital patients
Kidneys are predisposed to haemodynamic injury due to hypovolaemia or hypoperfusion
causes of acute kidney injury
pre renal
renal/ intrinsic
post renal
symptoms of acute kidney injury
oliguria - low urine output
pre renal
hypovolaemia
decreased cardiac output
decreased effective circulating volume - chf/ liver failure
impaired renal autoregulation - nsaids, ace/ arbs, cyclosporin
renal/ intrinsic
glomerular/vascular
sepsis
ischaemia
nephrotoxins
post renal
bladder outlet obstruction
bilateral pelvoureteral obstruction
prostaglandins and renal function
renal prostaglandins are vasodilator and natriuretic
biosynthesis is low under basal conditions
when vasocontrictors are released, local prostaglandins compensate to preserve renal blood flow
where is PGE2 active
renal medulla
where is PGI2 active
the glomeruli
NSAIDS and liver
nsaids have no effect on a healthy liver
however, if they are given to those with poor renal function, NSAIDS can increase blood pressure and salt and water retention and acute renal failure can occur
factors stimulating prostaglandin synthesis in kidneys
ischaemia
angiotensin II
ADH
bradkinin
drugs which cause renal failure if combined
RAAS inhibitor + NSAID + diuretic
acute kidney injury - the triple whammy
RAAS inhibitor - decrease glomerular filtration
NSAID - blockade of COX2 preventing prostacyclin synthesis = increased risk of AKI
Diuretic - can contribute to AKI by causing hypovolaemia
chronic kidney disease
reduction in GFR or urinary abnormalities
incidence increases with age
CKD and AKI are not mutually exclusive
RAAS plays a key role in the progression of CKD
renal effects of angiotensin II
short term increase GFR
long term can worsen CKD and cause glomerular scarring
cause of chronic kidney disease
ischaemic renal disease
metabolic disease (diabetes)
urinary tract diseases
renal stones
hereditary
chronic kidney disease can lead to
polyuria and nocturia
proteinuria and albuminuria
hypertension
anaemia
uraemia
bone disease
neurological changes
treatment/management of CKD
control BP
dietary modification
treat anaemia and nausea
manage vit d deficiency
osmotic diuresis
water is drawn
pulling effect